Using generative AI, researchers design compounds that can kill drug-resistant bacteria
The team used two different AI approaches to design novel antibiotics, including one that showed promise against MRSA.
The team used two different AI approaches to design novel antibiotics, including one that showed promise against MRSA.
A new approach for testing multiple treatment combinations at once could help scientists develop drugs for cancer or genetic disorders.
CellLENS reveals hidden patterns in cell behavior within tissues, offering deeper insights into cell heterogeneity — vital for advancing cancer immunotherapy.
The MIT-MGB Seed Program, launched with support from Analog Devices Inc., will fund joint research projects that advance technology and clinical research.
Researchers find nonclinical information in patient messages — like typos, extra white space, and colorful language — reduces the accuracy of an AI model.
Courses on developing AI models for health care need to focus more on identifying and addressing bias, says Leo Anthony Celi.
Trained with a joint understanding of protein and cell behavior, the model could help with diagnosing disease and developing new drugs.
Words like “no” and “not” can cause this popular class of AI models to fail unexpectedly in high-stakes settings, such as medical diagnosis.
A new book coauthored by MIT’s Dimitris Bertsimas explores how analytics is driving decisions and outcomes in health care.
A new method helps convey uncertainty more precisely, which could give researchers and medical clinicians better information to make decisions.